Search results for “Angiotensin II Receptor Blockers” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 359 patents, we discovered top 75 key players by total patent application. Novartis AG, HANALL BIOPHARMA Co., Ltd., Nicox SA are dominant in this area. They take 32.87% of the total patent filing.
Novartis AG
Basel-Stadt, Switzerland
Patent: 65
HANALL BIOPHARMA Co., Ltd.
South Korea
Patent: 28
Nicox SA
France
Patent: 25
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 21
Boryung Corp.
South Korea
Patent: 17
Daewoong Pharmaceutical Co., Ltd.
South Korea
Patent: 16
Wockhardt Ltd.
Maharashtra, India
Patent: 10
Rubicon Research Pvt Ltd.
Maharashtra, India
Patent: 10
Novartis Pharma GmbH
Austria
Patent: 10
Hoechst AG
Hessen, Germany
Patent: 9
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
STARTUP
Cirius Therapeutics, Inc.
Michigan, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 57 patents applied in the last 5 years. We discover 14 most active companies in this area. The fast-growing The George Institute for Global Health, AstraZeneca PLC, Chengdu Baiyu Pharmaceutical Co., Ltd. take 68.42% of patent filing during this period.
The George Institute for Global Health
New South Wales, Australia
Patent: 31
AstraZeneca PLC
Cambridgeshire, United Kingdom
Patent: 6
Chengdu Baiyu Pharmaceutical Co., Ltd.
Sichuan Sheng, China
Patent: 2
Hetero Labs Ltd.
Telangana, India
Patent: 2
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 2
Suzhou Xuhui Testing Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Alembic Pharmaceuticals Ltd.
Gujarat, India
Patent: 1
Zhejiang University
Zhejiang Sheng, China
Patent: 1
Changchun Haiwang Biological Pharmaceutical Co.,Ltd.
China
Patent: 1
Zaporizhia State Medical University
undefined undefined
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 57 patents in last 5 years, we discover 11 new entrants. AstraZeneca PLC, Chengdu Baiyu Pharmaceutical Co., Ltd., Hetero Labs Ltd. are the most active new entrants in this area.
AstraZeneca PLC
Cambridgeshire, United Kingdom
Patent: 6
Chengdu Baiyu Pharmaceutical Co., Ltd.
Sichuan Sheng, China
Patent: 2
Hetero Labs Ltd.
Telangana, India
Patent: 2
Suzhou Xuhui Testing Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Zaporizhia State Medical University
undefined undefined
Patent: 1
Oxford University Innovation Ltd.
United Kingdom
Patent: 1
Alembic Pharmaceuticals Ltd.
Gujarat, India
Patent: 1
Zhejiang University
Zhejiang Sheng, China
Patent: 1
AstraZeneca UK Ltd.
Cambridgeshire, United Kingdom
Patent: 1
Zealand Pharma A/S
Hovedstaden, Denmark
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 67 patents, we discovered top 8 universities and scientific research institutions by total patent application. The University of Sydney, Osaka University, Colorado State University are dominant in this area. They take 74.63% of the total patent filing.
The University of Sydney
Australia
Patent: 7
Osaka University
Osaka-fu, Japan
Patent: 4
Colorado State University
Colorado, United States
Patent: 3
Donghua University
Shanghai Shi, China
Patent: 3
Nara Medical University
Nara-ken, Japan
Patent: 3
Kharkiv National Medical University
Ukraine
Patent: 2
Zhejiang University
Zhejiang Sheng, China
Patent: 1
Odessa National Medical University
Ukraine
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: